NEXT GENERATION SEQUENCING (NGS) CONFIRMED THE ADVERSE CLINICAL IMPACT OF RUNX1 MUTATIONS IN A SUBSET OF ACUTE MYELOID LEUKEMIA NORMAL KARYOTYPE PATIENTS NEGATIVE FOR RISK DEFINING GENES MUTATIONS AND HOMOGENOUSLY TREATED WITHIN A CLINICAL TRIAL (NILG AML 02/06)

Salmoiraghi, S;Zanghi, P;Pavoni, C;Montalvo, MLG;Ubiali, G;Intermesoli, T;Oldani, E;Marmont, F;Cavattoni, I;Mattei, D;Terruzzi, E;De Paoli, L;Rossi, G;Borlenghi, E;Ciceri, F;Campiotti, L;Corradini, P;Cortelezzi, A;Ferrero, D;Audisio, E;Bosi, A;Bassan, R;Rambaldi, A;Spinelli, O

2017-01-01